Sellers, Kristin K. http://orcid.org/0000-0002-0517-2296
Cohen, Joshua L.
Khambhati, Ankit N.
Fan, Joline M.
Lee, A. Moses
Chang, Edward F.
Krystal, Andrew D. http://orcid.org/0000-0002-6702-781X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R213017912)
Ray and Dagmar Dolby Family Fund through the Department of Psychiatry and Behavioral Sciences at UCSF
Article History
Received: 7 March 2023
Revised: 31 May 2023
Accepted: 2 June 2023
First Online: 27 June 2023
Competing interests
: ADK Grant Support: Janssen Pharmaceuticals, Axsome Pharmaceutics, Attune, Harmony, Neurocrine Biosciences, Reveal Biosensors; Consulting; Axsome Therapeutics, Big Health, Eisai, Evecxia, Harmony Biosciences, Idorsia, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Millenium Pharmaceuticals, Merck, Neurocrine Biosciences, Neurawell Therapeutics, Otsuka Pharmaceuticals, Sage, Takeda, Angelini, Genentech. JLC served as a consultant for OptionsMD. The other authors declare no competing interests.